Zhejiang Shouxiangu Pharmaceutical Co., Ltd.

SHSE:603896 Voorraadrapport

Marktkapitalisatie: CN¥4.9b

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Zhejiang Shouxiangu Pharmaceutical Toekomstige groei

Future criteriumcontroles 2/6

Zhejiang Shouxiangu Pharmaceutical is forecast to grow earnings and revenue by 14.9% and 13.4% per annum respectively. EPS is expected to grow by 14.2% per annum. Return on equity is forecast to be 12.9% in 3 years.

Belangrijke informatie

14.9%

Groei van de winst

14.2%

Groei van de winst per aandeel

Personal Products winstgroei21.1%
Inkomstengroei13.4%
Toekomstig rendement op eigen vermogen12.9%
Dekking van analisten

Low

Laatst bijgewerkt24 Sep 2024

Recente toekomstige groei-updates

Recent updates

Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

May 02
Weak Statutory Earnings May Not Tell The Whole Story For Zhejiang Shouxiangu Pharmaceutical (SHSE:603896)

Winst- en omzetgroeiprognoses

SHSE:603896 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (CNY Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/20261,090383N/A4252
12/31/2025972335N/A3822
12/31/2024871289N/A3252
6/30/2024765265-365283N/A
3/31/2024799269-256286N/A
12/31/2023784254-99315N/A
9/30/2023864287-31316N/A
6/30/2023851286173318N/A
3/31/2023832281172339N/A
12/31/2022829278159341N/A
9/30/2022795244140334N/A
6/30/2022799228139339N/A
3/31/2022797219123310N/A
12/31/2021767201135297N/A
9/30/2021722172153281N/A
6/30/2021717164204300N/A
3/31/2021677160192284N/A
12/31/2020636152191256N/A
9/30/2020597134172241N/A
6/30/2020529119147209N/A
3/31/202051411396179N/A
12/31/2019547124116208N/A
9/30/201953110596191N/A
6/30/201953910090180N/A
3/31/2019550115-20186N/A
12/31/2018511108-61172N/A
9/30/201846198-75153N/A
6/30/2018430102-78147N/A
3/31/2018409100N/A131N/A
12/31/201737089N/A111N/A
9/30/201734289N/A113N/A
6/30/201733385N/A100N/A
3/31/201731784N/A101N/A
12/31/201631581N/A96N/A
12/31/201530263N/A85N/A
12/31/201430269N/A103N/A
12/31/201325354N/A66N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: 603896's forecast earnings growth (14.9% per year) is above the savings rate (2.9%).

Winst versus markt: 603896's earnings (14.9% per year) are forecast to grow slower than the CN market (23.2% per year).

Hoge groeiwinsten: 603896's earnings are forecast to grow, but not significantly.

Omzet versus markt: 603896's revenue (13.4% per year) is forecast to grow faster than the CN market (13.2% per year).

Hoge groei-inkomsten: 603896's revenue (13.4% per year) is forecast to grow slower than 20% per year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: 603896's Return on Equity is forecast to be low in 3 years time (12.9%).

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y